Jpmorgan Chase & CO Fulgent Genetics, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 338,044 shares of FLGT stock, worth $6.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

338,044

Previous 158,567 113.19%

Holding current value

$6.04 Million

Previous $3.11 Million 136.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$19.6 - $25.06 $3.52 Million - $4.5 Million	179,477 Added 113.19%	338,044 $7.34 Million
Q2 2024 Aug 12, 2024	SELL	$19.09 - $22.57 $1,164 - $1,376	-61 Reduced 0.04%	158,567 $3.11 Million
Q1 2024 May 10, 2024	SELL	$21.55 - $29.29 $3.81 Million - $5.18 Million	-176,775 Reduced 52.71%	158,628 $3.44 Million
Q4 2023 Feb 12, 2024	BUY	$23.64 - $30.27 $1.08 Million - $1.38 Million	45,661 Added 15.76%	335,403 $9.7 Million
Q3 2023 Nov 14, 2023	SELL	$26.74 - $40.81 $372,381 - $568,320	-13,926 Reduced 4.59%	289,742 $7.75 Million
Q2 2023 Aug 11, 2023	SELL	$28.52 - $40.7 $1.11 Million - $1.58 Million	-38,938 Reduced 11.37%	303,668 $11.2 Million
Q1 2023 May 18, 2023	BUY	$29.39 - $36.27 $755,029 - $931,776	25,690 Added 8.11%	342,606 $10.7 Million
Q1 2023 May 11, 2023	SELL	$29.39 - $36.27 $611,899 - $755,141	-20,820 Reduced 6.16%	316,916 $9.89 Million
Q4 2022 Feb 13, 2023	BUY	$29.23 - $40.28 $4.23 Million - $5.83 Million	144,660 Added 74.92%	337,736 $10.1 Million
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $4.2 Million - $7.06 Million	110,804 Added 134.68%	193,076 $7.36 Million
Q2 2022 Aug 11, 2022	BUY	$47.98 - $62.75 $183,043 - $239,391	3,815 Added 4.86%	82,272 $4.49 Million
Q1 2022 May 11, 2022	BUY	$49.85 - $96.11 $2.98 Million - $5.74 Million	59,711 Added 318.53%	78,457 $4.9 Million
Q4 2021 Feb 10, 2022	SELL	$77.3 - $105.0 $30.5 Million - $41.5 Million	-394,833 Reduced 95.47%	18,746 $1.89 Million
Q3 2021 Nov 12, 2021	BUY	$74.87 - $110.87 $31 Million - $45.9 Million	413,579 New	413,579 $37.2 Million

Others Institutions Holding FLGT

# of Institutions

201

Shares Held

16.1M

Call Options Held

2.04M

Put Options Held

14K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $541M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Fulgent Genetics, Inc. Transaction History